Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

23Andme Holding Co. (ME)

23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
23andMe and Mirador Therapeutics Forge Strategic Research Collaboration to Advance Precision Medicine in Immunology and Inflammation Quiver Quantitative, Inc. - Wed Nov 20, 4:48PM CST

23andMe and Mirador Therapeutics announce a collaboration to enhance precision medicine for immunology and inflammation diseases using genetic data.Quiver AI Summary23andMe Holding Co. and Mirador Therapeutics...

ME : 3.23 (+2.54%)
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation GlobeNewswire - Wed Nov 20, 6:30AM CST

ME : 3.23 (+2.54%)
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results GlobeNewswire - Tue Nov 12, 6:30AM CST

ME : 3.23 (+2.54%)
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future GlobeNewswire - Mon Nov 11, 4:30PM CST

ME : 3.23 (+2.54%)
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results GlobeNewswire - Thu Nov 7, 4:54PM CST

ME : 3.23 (+2.54%)
23andMe to Report Q2 FY2025 Financial Results GlobeNewswire - Thu Nov 7, 6:30AM CST

ME : 3.23 (+2.54%)
23andMe Regains Compliance With Nasdaq Listing Requirements GlobeNewswire - Wed Oct 30, 4:00PM CDT

ME : 3.23 (+2.54%)
23andMe Appoints Three New Independent Directors to Board GlobeNewswire - Tue Oct 29, 6:30AM CDT

ME : 3.23 (+2.54%)
ASML's Latest Chapter in the Semiconductor Story Motley Fool - Tue Oct 22, 9:54AM CDT

We've also got a look at genetic testing company 23andMe .

TGT : 121.59 (-0.11%)
RAD.AX : 0.026 (unch)
CVS : 57.10 (+0.48%)
INTC : 24.44 (+1.79%)
WBA : 8.30 (+0.73%)
ME : 3.23 (+2.54%)
BKNG : 5,210.92 (+3.88%)
AMZN : 198.38 (-2.22%)
ASML : 672.16 (+2.09%)
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South GlobeNewswire - Thu Oct 17, 3:05PM CDT

ME : 3.23 (+2.54%)

Barchart Exclusives

Up 882% YTD, Is It Too Late to Buy This Fintech Stock? Barchart - 27 minutes ago
A recent guidance boost from DAVE propelled the stock even higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot